Skip to main content
. 2023 Jul 1;31(4):395–401. doi: 10.4062/biomolther.2023.099

Table 1.

Inflammatory diseases and their NLRP3 activators and cytokines which is released by NLRP3 activation to specific diseases respectively

Disease NLRP3 Activators Cytokines References
Asthma Various pathogens, toxins, bacteria, RNA and Der f1 IL-1β, IL-18 Whelan et al., 2004; Mariathasan and Monack, 2007; Besnard et al., 2011; Tsai et al., 2018
Atopic Dermatitis Staphylococcus aureus, S. aureus linked α-toxins IL-1β, IL-18, IL-5, IL-31 Marples et al., 1973; Tomi et al., 2005; Arend et al., 2008; Munoz-Planillo et al., 2009; Boguniewicz and Leung, 2010; Niebuhr et al., 2014
Sepsis ROS, mtDNA,TLR4 agonist and LPS IL-1β, IL-18, IL-33 Martin et al., 2003; Bauernfeind et al., 2009; Willingham et al., 2009; Yin et al., 2011; Kamo et al., 2013; Luo et al., 2014